Emicizumab-kxwh and Lorcaserin Extended-Release Tablets
Determining the interaction of Emicizumab-kxwh and Lorcaserin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-kxwh-Lorcaserin Hydrochloride
- Emicizumab-kxwh-Lorcaserin Tablets
- Emicizumab-kxwh-Lorcet
- Emicizumab-kxwh-Lorcet Plus
- Emicizumab-kxwh-Lorcet Tablets
- Emicizumab-kxwh-Lorlatinib
- Lorcaserin Extended-Release Tablets-Emicizumab-kxwh Subcutaneous
- Lorcaserin Extended-Release Tablets-Emla
- Lorcaserin Extended-Release Tablets-Emla Topical
- Lorcaserin Extended-Release Tablets-Emo-Cort Scalp Solution Topical application
- Lorcaserin Extended-Release Tablets-Emo-Cort Topical application
- Lorcaserin Extended-Release Tablets-Emoquette